Su, Liyu
Chen, Mingqiu
Su, Huiyan
Dai, Yaqing
Chen, Shaoxing
Li, Jiancheng
Funding for this research was provided by:
Fujian Provincial Health & Family Planning Commission (2016-ZQN-13,2016-ZQN-32)
Fujian Provincial Department of Science & Technology (2017Y9079)
Fujian Provincial Platform for Medical Laboratory Research and Key Laboratory for Tumor Individualized Active Immunity (FYKFKT-2017015)
Science and Technology Program of Fujian Province (2018Y2003)
Article History
Received: 7 March 2019
Accepted: 6 September 2019
First Online: 30 October 2019
Ethics approval and consent to participate
: This retrospective study was approved by Fujian Province Cancer Hospital Institutional Review Board (No. KT-2018-015-01). All patients provided written informed consent prior to treatment, and all information was anonymized prior to analysis.
: Not applicable.
: The authors declare the submitted work was not carried out in the presence of any personal, professional or financial relationships that could potentially be construed as a conflict of interest.